PKAAX
Price
$13.71
Change
-$0.07 (-0.51%)
Updated
Aug 15 closing price
Net Assets
1.37B
VIVIX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

PKAAX vs VIVIX

Header iconPKAAX vs VIVIX Comparison
Open Charts PKAAX vs VIVIXBanner chart's image
PIMCO RAE US A
Price$13.71
Change-$0.07 (-0.51%)
VolumeN/A
Net Assets1.37B
Vanguard Value Index I
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
PKAAX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PKAAX vs. VIVIX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PKAAX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. PKAAX (1.37B). VIVIX pays higher dividends than PKAAX: VIVIX (2.19) vs PKAAX (1.48). PKAAX was incepted earlier than VIVIX: PKAAX (10 years) vs VIVIX (27 years). PKAAX (0.81) is less costly to investors than VIVIX (0.04). PKAAX is a more actively managed with annual turnover of: 73.00 vs. VIVIX (9.00). PKAAX has a lower initial minimum investment than VIVIX: PKAAX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.91 vs. PKAAX (-1.13). VIVIX return over 5 years is better than : 68.54 vs. PKAAX (45.36).
PKAAXVIVIXPKAAX / VIVIX
Total Expense Ratio0.800.042,000%
Annual Report Gross Expense Ratio0.810.042,025%
Fund Existence10 years27 years-
Gain YTD8.1236.533124%
Front Load4%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B196B1%
Annual Yield % from dividends1.482.1968%
Returns for 1 year-1.137.91-14%
Returns for 3 years12.2125.9347%
Returns for 5 years45.3668.5466%
Returns for 10 years65.85114.6157%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALFVY44.210.28
+0.63%
Alfa-Laval AB
HZNOF7.20N/A
N/A
DEXTERRA GROUP INC.
NICXF0.30N/A
N/A
Nicox S.A.
NVRVF0.06N/A
N/A
Novra Technologies Inc
MEPDF15.90N/A
N/A
Medipal Holdings Corp.